Rosemary A. Crane

Companies

• Certara, Inc.Board member Jul 22, 2022 to now¹
• Teva Pharmaceutical Industries Ltd.Board member Jan 2, 2018 to now²
• Tarsus Pharmaceuticals, Inc.Board member Aug 12, 2021 to Jun 25, 2024³
• Catalent Pharma SolutionsBoard member Feb 21, 2018 to Oct 31, 2023⁴
• PDS Biotechnology CorpBoard member Sep 19, 2017 to Mar 18, 2019⁵
• MELA SciencesBoard member Nov 13, 2013 to Feb 6, 2014⁶
• MELA SciencesChief executive officer Nov 13, 2013 to Feb 6, 2014⁶
• MELA SciencesPresident Nov 13, 2013 to Feb 6, 2014⁶
• EpocratesBoard member Feb 1, 2011 to Mar 28, 2011⁷
• EpocratesChief executive officer Feb 1, 2011 to Mar 28, 2011⁷
• EpocratesPresident Feb 1, 2011 to Mar 28, 2011⁷
• Targanta Therapeutics CorporationBoard member Aug 26, 2008 to Aug 26, 2008⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Teva Pharmaceutical Industries Ltd. TEVA127,739 shares⁹$5.3M at $41.41Jun 5, 2026
• CCertara, Inc. CERT45,672 shares¹⁰$430.9K at $9.44May 14, 2026
• TPTarsus Pharmaceuticals, Inc. TARS5,350 shares¹¹$372.6K at $69.64Jun 24, 2024
• Catalent Pharma Solutions CTLT23,873 shares¹²Oct 27, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 5, 2026Exercised options 14,492 shares of Teva Pharmaceutical Industries Ltd.⁹
• May 14, 2026Exercised options 15,757 shares of Certara, Inc.¹⁰
• Jun 6, 2025Exercised options 9,632 shares of Teva Pharmaceutical Industries Ltd.¹³
• May 21, 2025Exercised options 11,928 shares of Certara, Inc.¹⁴
• Jun 24, 2024Exercised options 3,350 shares of Tarsus Pharmaceuticals, Inc.¹¹
• Jun 15, 2024Exercised options 21,108 shares of Teva Pharmaceutical Industries Ltd.¹⁵
• May 21, 2024Exercised options 8,663 shares of Certara, Inc.¹⁶
• Oct 27, 2023Granted 6,993 shares of Catalent Pharma Solutions¹²
• Aug 4, 2023Exercised options 15,810 shares of Teva Pharmaceutical Industries Ltd.¹⁷
• Jun 16, 2023Exercised options 2,000 shares of Tarsus Pharmaceuticals, Inc.¹⁸
• May 23, 2023Exercised options 9,324 shares of Certara, Inc.¹⁹
• Oct 27, 2022Granted 4,149 shares of Catalent Pharma Solutions²⁰
• Jun 14, 2022Exercised options 14,479 shares of Teva Pharmaceutical Industries Ltd.²¹
• Oct 28, 2021Granted 1,402 shares of Catalent Pharma Solutions²²